Cholesterol-lowering drug may protect stem cell transplant patient from potentially deadly complication
Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the US. Now a new study by researchers at Fred Hutchinson Cancer Research Center indicates that statins may protect stem cell transplant patients from one of the most serious complications of the life-saving cancer therapy: graft-versus-host disease, or GVHD. The findings are reported in the December 4 edition …
[Read the full article here]Related News:
Cholesterol-Lowering Drugs Also May Protect Stem Cell Transplant Patients From A Potentially Deadly Complication
Statins may help protect stem cell transplant patients from GVHD
Statins studied in stem cell transplants